Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson’s disease and OFF episodes: post hoc analyses of a phase III, open-label study
Background: Managing OFF episodes in patients with Parkinson’s disease becomes increasingly challenging over time, making it critical to tailor treatment to each patient’s needs and characteristics for effective care. Objectives: Study CTH-301 assessed the long-term safety/tolerability and efficacy...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publishing
2025-06-01
|
| Серии: | Therapeutic Advances in Neurological Disorders |
| Online-ссылка: | https://doi.org/10.1177/17562864251343583 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
